Novo Nordisk A/s

Kim Vilbour Andersen

Sven Hastrup

Henning Thoegersen

Kristian Sass-Oerum

Sebastian Beck Joergensen

Allan Christian Shaw

Charlotte Helgstrand

Michael Paolo Bastner Sandrini

Michael P Bastner Sandrini

The invention relates to MIC-1 fusion proteins. More specifically it relates to compounds comprising fusion proteins comprising a MIC-1 protein or an analog thereof at the C-terminus of the fusion protein and a functional variant of human serum albumin at the N-terminus of the fusion protein connected via a peptide linker. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds.

MIC-1 fusion proteins and uses thereof

Growing community of inventors

Bagsvaerd, Denmark

Kim Vilbour Andersen